KRAS and leukoencephalopathy with calcifications and cysts: A higher percentage of K-RAS mutation (48.5% vs. 31.6%, p < 0.01) and deficient MMR (dMMR) (45.5% vs. 18.2%, p < 0.01) were noted in patients with RCC than in patients with LCC.